Wednesday, May 22, 2019 2:52:06 PM
Here is part of the article that most noobie investors would have laughed at - but it duped a few that didn't know what a provisional patent meant.
"Teva’s bid for OWC’s patents also makes sense for the company, and its move into the medical marijuana market is likely to be more than mere experimentation."
There was never a bid because OWCP doesn't own any patents.
Plus, there was a grievous error that most would have easily found.
"Multiple myeloma is the second most common blood cancer after non-Hodgkin lymphoma. It affects six out of every 100,00 people"
That would mean that MM wouldn't qualify for Orphan Drug Status.
IB
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM